Delivery Order SPE2DB22D6029-SPE2DB25FLVCG
Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- The Defense Logistics Agency awarded a $2,072.25 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials, with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing for pharmaceutical supply fulfillment. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency valued at $2,752.23 for Pegasys 180 mcg/0.5 mL syringes. The contract is non-set-aside and competitively awarded on a firm fixed price basis, with an ultimate completion date of September 17, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,261.21 by the Defense Logistics Agency (DLA) for the supply of Pegasys 180 mcg/ml vials. The award, issued on July 28, 2025, is a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,072.25 by the Defense Logistics Agency's Medical Supply Chain for the procurement of Pegasys 180 mcg/ml vials. This firm fixed-price, competitively awarded contract (no set-aside) was issued on September 10, 2025, with an ultimate completion date of September 11, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its Corporate Office location. This delivery order represents a child award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,515.38 for Pegasys 180 mcg/ml vials on April 21, 2025, with completion scheduled for April 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate office location in Conshohocken, PA. The award is funded by the Defense Logistics Agency's Medical Supply...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEGASYS 180 MCG/ML VIALML pharmaceuticals. The contract has a potential value of $8,220.18 and a completion date of January 26, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.25 firm fixed-price delivery order contract provides for PEGASYS 180 MCG/ML VIALML, with a completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $6,706.70, this order is for the supply of 180 mcg/ml vials of PEGASYS to support DLA medical treatment programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by December 8, 2023. No set-aside designation was applied to this award issued by...